Time‐dependent impact of type 2 diabetes mellitus on incident prodromal Alzheimer disease: A longitudinal study in 1395 participants

This study was undertaken to investigate the longitudinal impact of type 2 diabetes mellitus (T2DM) on the prodromal and dementia stages of Alzheimer disease (AD), focusing on diabetes duration and other comorbidities.

[1]  L. Fratiglioni,et al.  Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry , 2022, European heart journal.

[2]  R. Bateman,et al.  Lecanemab in Early Alzheimer's Disease. , 2022, The New England journal of medicine.

[3]  L. Fratiglioni,et al.  Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  T. Littlejohns,et al.  Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study , 2022, The Lancet. Healthy longevity.

[5]  F. Barkhof,et al.  Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease , 2022, The Journal of Prevention of Alzheimer's Disease.

[6]  L. Fratiglioni,et al.  The impact of diabetes on cognitive impairment and its progression to dementia : A population-based cohort study , 2019 .

[7]  B. Hyman,et al.  APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. , 2021, The Lancet Neurology.

[8]  S. Craft,et al.  Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches , 2020, The Lancet Neurology.

[9]  J. Suckling,et al.  Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  A. Sinclair,et al.  Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. , 2020, The lancet. Diabetes & endocrinology.

[11]  C. Iadecola,et al.  Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension , 2020, Hypertension.

[12]  T. Nguyen,et al.  Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease , 2020, International journal of molecular sciences.

[13]  J. Tolstrup,et al.  Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals , 2020, Epidemiology and Psychiatric Sciences.

[14]  A. Fagan,et al.  APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.

[15]  B. Nordestgaard,et al.  Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals , 2020, Diabetologia.

[16]  M. Carnethon,et al.  Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. , 2020, The lancet. Diabetes & endocrinology.

[17]  C. Dintica,et al.  Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study , 2019, Alzheimer's & Dementia.

[18]  M. Albert,et al.  The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study , 2019, Diabetes Care.

[19]  D. Nation,et al.  Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer’s Disease , 2019, Diabetes Care.

[20]  Yu-yan Xu,et al.  The risk factors for diabetic peripheral neuropathy: A meta-analysis , 2019, PloS one.

[21]  Can Zhang,et al.  Models for predicting risk of dementia: a systematic review , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  N. Somasundaram,et al.  Prevalence of Chronic Complications, Their Risk Factors, and the Cardiovascular Risk Factors among Patients with Type 2 Diabetes Attending the Diabetic Clinic at a Tertiary Care Hospital in Sri Lanka , 2018, Journal of diabetes research.

[23]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[24]  F. Schmitt,et al.  Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.

[25]  Jennifer Y. Liu,et al.  Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events , 2016, Journal of General Internal Medicine.

[26]  M. Woodward,et al.  Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia , 2015, Diabetes Care.

[27]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[28]  G. Berrut,et al.  Association Between Comorbidity Burden and Rapid Cognitive Decline in Individuals with Mild to Moderate Alzheimer's Disease , 2015, Journal of the American Geriatrics Society.

[29]  Jennifer Y. Liu,et al.  Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. , 2014, JAMA internal medicine.

[30]  Nicolas Cherbuin,et al.  A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI , 2014, PloS one.

[31]  A. Zechariah,et al.  Hyperlipidemia Attenuates Vascular Endothelial Growth Factor–Induced Angiogenesis, Impairs Cerebral Blood Flow, and Disturbs Stroke Recovery via Decreased Pericyte Coverage of Brain Endothelial Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Alina Solomon,et al.  Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia , 2011, International journal of geriatric psychiatry.

[33]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[34]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[35]  L. Fratiglioni,et al.  Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.

[36]  B. Winblad,et al.  The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease , 2007, Diabetes.

[37]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[38]  G. Mcclearn,et al.  Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old , 2002, International Psychogeriatrics.

[39]  J. Cummings,et al.  Prevalence and impact of medical comorbidity in Alzheimer's disease. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[41]  L. Kuller,et al.  Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. , 2008, Archives of neurology.

[42]  吉武毅人.  Incidence and risk factors of vascular dementia and Alzheimer′s disease in a defined elderly Japanese population: The Hisayama Study(一般住民中の高齢者における脳血管性痴呆アルツハイマー病の発症率と危険因子の検討: 久山町研究) , 1997 .